NHS SCOTLAND
Providing advice about the status of all newly licensed medicines
| Drug Number: | 481/08 |
| Drug Name: | docetaxel (Taxotere) |
| Drug Manufacturer: | Sanofi-Aventis |
| BNF Category: | Malignant disease and immunosuppression |
| Submission type : | Full submission |
| Date Advice Issued: | 07 July 2008 |
| Indication: | In combination with cisplatin and 5-fluorouracil (5-FU) is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck |
There is currently no other SMC advice for this product